BWXT can trace its history back 180 years in Canada with global leadership in the design, manufacture, and service of commercial nuclear components for more than five decades. We’re proud to celebrate our talented and diverse employees this Canada Day! #CanadaDay
About us
BWXT Medical Ltd. manufactures custom radiopharmaceuticals, radiotherapies and medical isotopes in an 80,000-square-foot cGMP manufacturing facility in Ottawa and at the state-of-the-art commercial cyclotron facility within TRIUMF, Canada’s particle acceleration centre. BWXT Medical Ltd. is a subsidiary of BWX Technologies, Inc. (NYSE: BWXT). BWXT is a manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, environmental restoration, nuclear medicine and space exploration. For more information, visit www.bwxt.com. Follow us on LinkedIn, X, Facebook and Instagram.
- Website
-
https://www.bwxtmedical.com
External link for BWXT Medical Ltd.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Kanata, Ontario
- Type
- Public Company
- Specialties
- nuclear medicine, medical isotopes, and contract manufacturing
Locations
-
Primary
Get directions
447 March Rd
Kanata, Ontario K2K 1X8, CA
-
Get directions
4004 Wesbrook Mall
Vancouver, British Columbia V6T 2A3, CA
Employees at BWXT Medical Ltd.
Updates
-
We’re proud of our increasingly diverse workforce, and we celebrate diversity across Canada. This Canadian Multiculturalism Day, we recognize there is still work to be done to create more inclusive, safe and equal places for all. We encourage you to learn more about #MultiDay at https://lnkd.in/gDCuPBu5
-
-
Thank you, Women in Nuclear Canada, for stopping by our Ottawa facility! Our Vice President of Operations, Rachel Pickering, highlighted our employees’ significant contributions in the development of nuclear medicine products, which aid in diagnosing and treating disease. BWXT Medical is committed to increasing representation of women in the nuclear medicine industry and recognizes the importance of a diverse and inclusive workplace for all. We look forward to more opportunities to collaborate with Women in Nuclear Canada!
WiN Eastern Ontario members enjoyed technical tours of BWXT Medical Ltd. and Nordion this past Friday in both morning and afternoon sessions. Participants had the opportunity to see the development, manufacturing, and supply of products for industrial sterilization, cancer therapy, diagnostic imaging and radiotherapeutic treatments. From receiving to processing to shipment, it was fascinating to see all the innovative technology being developed and used to safeguard global health! Thank you to our hosts for the informative and enlightening tours.
-
-
Happy #INWED2024! International Women in Engineering Day plays a vital role in encouraging more young women and girls to pursue engineering and other STEM careers. BWXT is proud to support these efforts through our community engagement and recruitment efforts.
-
Today is National Indigenous Peoples Day in Canada. We are proud to celebrate and honor the important contributions of First Nations, Inuit and Métis and help build awareness about Indigenous culture and history. #NIPD #NationalIndigenousPeoplesDay
-
-
That’s a wrap! #SNMMI2024 was one of the best yet and was a fantastic experience to connect with industry peers and discuss the future of #NuclearMedicine. Thank you to everyone who stopped by the BWXT Medical booth. Society of Nuclear Medicine and Molecular Imaging (SNMMI) #HealthCare
-
-
It’s Day 3 of Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024! Be sure to visit the BWXT Medical team at Booth 1602 to learn about our latest innovations in nuclear medicine and how we directly impact patients worldwide. #SNMMI2024 #HealthCare #NuclearMedicine
-
The 2024 Canadian Radiotheranostics Leaders' Summit is a collaboration between the University Health Network and the Canadian Nuclear Isotope Council, in partnership with the Canadian Medical Isotope Ecosystem. The forum aims to highlight issues of greatest relevance in the Canadian landscape and shape the future to best serve patients and talent within the sector. At this year's event, our President and CEO Jonathan Cirtain hosted a networking reception, where he commended Ontario's commitment to growing its biomanufacturing and life sciences sector and the need for concerted effort and substantial government to enable it.
-
-
Our BWXT Medical team is ready to meet you at #SNMMI2024! We can’t wait to connect with industry peers and showcase our latest advancements in nuclear medicine. Visit Booth 1602 to learn more about how we’re innovating the nuclear medicine supply chain and patient care. #SNMMI #HealthCare #NuclearMedicine
-
We are pleased to announce that BWXT Medical has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient. BWXT Medical’s Ac-225 has been used in an early clinical study, and the DMF is now ready for reference to support later stage clinical studies and, ultimately, new drug applications. Jonathan Cirtain, president and chief executive officer of BWXT Medical, stated, “Our submission of a Drug Master File to the FDA marks a significant milestone for our company. This filing underscores our unwavering commitment to quality and regulatory excellence, ensuring that our medical isotopes meet the highest standards of safety and efficacy. It represents not just our dedication to advancing healthcare, but also our readiness to support our customers and partners in delivering critical treatments to patients in need.” https://lnkd.in/eQ86bdMm #News #BWXTNews
-